Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

NCT02994433 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02994433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02994433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Recruiting
Start date
January 27, 2017
Completion date
April 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, depressive disorder, treatment-resistant